ESE Basic Course on Endocrine and Neuroendocrine Cancer 2016

Advances in molecular pathogenesis of thyroid cancer

L1 Biographical Details

Telomerase promoter mutations in cancer: beyond immortalization?

L3 Biographical Details

Molecular Targeted Therapy in Medullary and Well-Differentiated Thyroid Carcinoma

L4 Biographical Details

Endocrine cancer: in the light of recent molecular studies

L5 Biographical Details

The genomic landscape of pancreatic neuroendocrine tumors

L6 Biographical Details

Anti-tumor effects of Semaphorin 4D blockade unravel a novel pro-invasive mechanism of vascular targeting agents in pNETs

L8 Biographical Details

Deciphering the antitumoral potential of stromal somatostatin receptor signal

L9 Biographical Details

ALTered telomeres in pancreatic neuroendocrine tumors

L10 Biographical Details

New insights on adrenocortical tumors OMICs

L11 Biographical Details

Identification of new familial pheochromocytoma/paraganglioma genes using next generation sequencing (NGS)

L12 Biographical Details

Cellular and animal models in Pheochromocytoma/Paragangliomas research: Role of microenvironment

L13 Biographical Details

Meet-the-Expert: From genetics to the bedside

L15 Biographical Details

AIP and the somatostatin signalling in pituitary tumours

L16 Biographical Details

Truncated sst5 receptor variants in pituitary tumors and cancer

L17 Biographical Details

Stem cells in pituitary … and in pituitary tumours?

L18 Biographical Details

Gigantism, acromegaly and GPR101

L19 Biographical Details

The bright and dark side of transthyretin, a thyroxine plasma transporter

L20 Biographical Details

Oral Communications

OC1 OC2 OC3 OC4 OC5 OC6 OC7 OC8

Poster Presentations

P1 P2 P3 P4 P5 P6 P7 P8 P9 P10 P11 P12 P13 P14 P15 P16 P17 P18 P19 P20 P21 P22 P23 P24 P25